Induction with anti-thymocyte globulin in heart transplantation is associated with better long-term survival compared with basiliximab

In the International Society for Heart and Lung Transplantation Registry experience, use of ATG rather than BAS as induction therapy appears to be associated with better long-term survival. A prospective study is necessary to confirm these findings.